Notably, COF‐loaded reuterin treatment significantly increased the proportion of CD86+ (M1‐like) macrophages while decreasing CD206+ (M2‐like) macrophages within the tumor microenvironment, indicating a shift toward a proinflammatory macrophage phenotype (Figure S15a–c, Supporting Information). The gene discussed is MRC1; the disease is neoplasm.